Overview
Mary Cunningham is an Oncologist practicing medicine in Columbia, Missouri.
Dr. Cunningham is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Dr. Cunningham is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
Locations
3217 S Providence Rd, Columbia, MO 65203
Boone Hospital Center
Umasankar Ramadoss is a Hematologist and an Oncologist practicing medicine in Columbia, Missouri. Dr. Ramadoss is highly rated in 83 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, Bone Marrow Aspiration, and Liver Embolization.
Missouri Cancer Associates Rrl
Mark Tungesvik is an Oncologist practicing medicine in Columbia, Missouri. Dr. Tungesvik is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Bone Marrow Aspiration, and Endoscopy. Dr. Tungesvik is currently accepting new patients.
The Curators Of The University Of Missouri
Puja Nistala is a Hematologist and an Oncologist practicing medicine in Columbia, Missouri. Dr. Nistala is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Bone Marrow Aspiration. Dr. Nistala is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine/Hematology. Dr. Nistala is currently accepting new patients.
Frequently Asked Questions about Dr. Mary L. Cunningham
How do I make an appointment with Dr. Mary L. Cunningham?
You can book an appointment with Dr. Mary L. Cunningham by calling their office at 573-884-7733. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mary L. Cunningham a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mary L. Cunningham is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mary L. Cunningham specialize in?
While Dr. Mary L. Cunningham is a Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Mary L. Cunningham accept my insurance?
Dr. Mary L. Cunningham accepts most major insurance plans, including Blue Shield of California and Health Alliance. We recommend calling the office directly at 573-884-7733 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult Soft Tissue SarcomaDr. Cunningham isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Cunningham isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Bone TumorDr. Cunningham isAdvanced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Cunningham isAdvanced. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Cunningham isAdvanced. Learn about Fibrosarcoma.
- LiposarcomaDr. Cunningham isAdvanced. Learn about Liposarcoma.
- Lung AdenocarcinomaDr. Cunningham isAdvanced. Learn about Lung Adenocarcinoma.
- MesenchymomaDr. Cunningham isAdvanced. Learn about Mesenchymoma.
- Myxoid LiposarcomaDr. Cunningham isAdvanced. Learn about Myxoid Liposarcoma.
- Pleuropulmonary BlastomaDr. Cunningham isAdvanced. Learn about Pleuropulmonary Blastoma.
- Rhabdomyosarcoma EmbryonalDr. Cunningham isAdvanced. Learn about Rhabdomyosarcoma Embryonal.
- Small Cell Lung Cancer (SCLC)Dr. Cunningham isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Cunningham isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Undifferentiated Pleomorphic SarcomaDr. Cunningham isAdvanced. Learn about Undifferentiated Pleomorphic Sarcoma.
- Experienced
- ChordomaDr. Cunningham isExperienced. Learn about Chordoma.
- Colorectal CancerDr. Cunningham isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Cunningham isExperienced. Learn about EGFR Positive Lung Cancer.
- Endometrial CancerDr. Cunningham isExperienced. Learn about Endometrial Cancer.
- Ewing SarcomaDr. Cunningham isExperienced. Learn about Ewing Sarcoma.
- Familial Colorectal CancerDr. Cunningham isExperienced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Cunningham isExperienced. Learn about Familial Pancreatic Cancer.
- Large-Cell Lung CarcinomaDr. Cunningham isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung CancerDr. Cunningham isExperienced. Learn about Lung Cancer.
- Lynch SyndromeDr. Cunningham isExperienced. Learn about Lynch Syndrome.
- MesotheliomaDr. Cunningham isExperienced. Learn about Mesothelioma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Cunningham isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pancreatic CancerDr. Cunningham isExperienced. Learn about Pancreatic Cancer.